EE03663B1 - Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine - Google Patents

Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine

Info

Publication number
EE03663B1
EE03663B1 EEP199900162A EE9900162A EE03663B1 EE 03663 B1 EE03663 B1 EE 03663B1 EE P199900162 A EEP199900162 A EE P199900162A EE 9900162 A EE9900162 A EE 9900162A EE 03663 B1 EE03663 B1 EE 03663B1
Authority
EE
Estonia
Prior art keywords
product
active ingredient
breast cancer
pharmaceutical preparation
preventing breast
Prior art date
Application number
EEP199900162A
Other languages
English (en)
Estonian (et)
Other versions
EE9900162A (et
Inventor
J. Cohen Fredric
S. Eckert Robert
E. Glusman Joan
K. Knickerbocker Ronald
T. Nickelsen Nikolaus
J. Scott Teri
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03663(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of EE9900162A publication Critical patent/EE9900162A/xx
Publication of EE03663B1 publication Critical patent/EE03663B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP199900162A 1996-10-30 1997-10-29 Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine EE03663B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10
PCT/US1997/019779 WO1998018449A1 (en) 1996-10-30 1997-10-29 Methods of preventing breast cancer

Publications (2)

Publication Number Publication Date
EE9900162A EE9900162A (et) 1999-12-15
EE03663B1 true EE03663B1 (et) 2002-04-15

Family

ID=27268608

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900162A EE03663B1 (et) 1996-10-30 1997-10-29 Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine

Country Status (44)

Country Link
US (2) US6303634B1 (es)
EP (3) EP0839532B1 (es)
JP (2) JPH10147530A (es)
CN (2) CN1182591A (es)
AP (1) AP971A (es)
AR (2) AR013864A1 (es)
AT (2) ATE338551T1 (es)
AU (3) AU5005197A (es)
BE (2) BE1011381A5 (es)
BG (1) BG63841B1 (es)
BR (1) BR9712703A (es)
CA (2) CA2219377A1 (es)
CH (2) CH693820A5 (es)
CZ (2) CZ341297A3 (es)
DE (2) DE69721692T2 (es)
DK (2) DK0839532T3 (es)
EA (2) EA006083B1 (es)
EE (1) EE03663B1 (es)
ES (4) ES2135343A1 (es)
FR (2) FR2756490B1 (es)
GB (3) GB2318733A (es)
GE (1) GEP20032910B (es)
GR (2) GR1003189B (es)
HK (1) HK1010495A1 (es)
HU (2) HUP9701777A3 (es)
IE (2) IE970772A1 (es)
IL (2) IL122026A0 (es)
IS (1) IS5035A (es)
IT (2) IT1298470B1 (es)
LU (2) LU90157B1 (es)
LV (1) LV12353B (es)
MY (1) MY121623A (es)
NL (2) NL1007387C2 (es)
NO (2) NO974973D0 (es)
NZ (1) NZ329042A (es)
PT (2) PT839532E (es)
RO (1) RO120813B1 (es)
SG (2) SG83672A1 (es)
SI (3) SI20107A (es)
SK (1) SK287047B6 (es)
TR (1) TR199900951T2 (es)
UA (1) UA46762C2 (es)
WO (2) WO1998018325A1 (es)
YU (1) YU42397A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1395563B1 (en) 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US6962928B2 (en) 2001-05-22 2005-11-08 Eli Lilly And Company Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
IL111287A0 (en) * 1993-10-15 1994-12-29 Lilly Co Eli Methods for treating resistant neoplasms
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
IL112746A (en) * 1994-03-02 1999-12-31 Lilly Co Eli Orally administrable pharmaceutical formulation comprising raloxifene hydrochoride
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.

Also Published As

Publication number Publication date
GEP20032910B (en) 2003-03-25
GB2318733A (en) 1998-05-06
AP9901494A0 (en) 1999-03-31
CN1182590A (zh) 1998-05-27
WO1998018325A1 (en) 1998-05-07
SG83672A1 (en) 2001-10-16
GB2318734A (en) 1998-05-06
HUP9701777A3 (en) 1999-07-28
AU5005197A (en) 1998-05-22
NO974972L (no) 1998-05-04
PT839532E (pt) 2003-09-30
ES2135342B1 (es) 2000-05-16
DE69721692T2 (de) 2004-03-25
IL122026A0 (en) 1998-03-10
ITMI972433A1 (it) 1999-04-29
US20020019418A1 (en) 2002-02-14
ITMI972434A1 (it) 1999-04-29
EP1369115A1 (en) 2003-12-10
DE69736644T2 (de) 2007-10-25
NL1007386C2 (nl) 1998-05-14
ES2197312T3 (es) 2004-01-01
FR2755014B1 (fr) 1999-02-05
FR2756490A1 (fr) 1998-06-05
ES2135343A1 (es) 1999-10-16
EA002054B1 (ru) 2001-12-24
NZ329042A (en) 1999-08-30
CA2219070C (en) 2007-12-18
SI20107A (sl) 2000-06-30
CZ300261B6 (cs) 2009-04-01
NO974972D0 (no) 1997-10-28
EP0839532B1 (en) 2003-05-07
US6303634B1 (en) 2001-10-16
EA200100716A1 (ru) 2002-06-27
SK287047B6 (sk) 2009-10-07
GB2318734B (en) 1999-12-01
AU4364797A (en) 1998-05-07
CH691847A5 (fr) 2001-11-15
AU5005697A (en) 1998-05-22
FR2755014A1 (fr) 1998-04-30
CZ341197A3 (cs) 1998-05-13
GR970100408A (el) 1998-06-30
TR199900951T2 (xx) 1999-07-21
GR1003189B (el) 1999-09-01
UA46762C2 (uk) 2002-06-17
CA2219377A1 (en) 1998-04-30
IE970773A1 (en) 2000-02-09
CA2219070A1 (en) 1998-04-30
NO974973D0 (no) 1997-10-28
LU90157B1 (fr) 1998-06-02
JPH10147530A (ja) 1998-06-02
ES2271476T3 (es) 2007-04-16
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
ATE338551T1 (de) 2006-09-15
CZ341297A3 (cs) 1998-05-13
HUP9701778A3 (en) 1999-06-28
EA199900431A1 (ru) 1999-10-28
IT1298470B1 (it) 2000-01-10
CN1182591A (zh) 1998-05-27
NL1007387C2 (nl) 1998-05-14
LV12353A (lv) 1999-10-20
LV12353B (en) 2000-02-20
IL122025A0 (en) 1998-03-10
AR013864A1 (es) 2001-01-31
GR970100409A (el) 1998-06-30
ES2135342A1 (es) 1999-10-16
EA006083B1 (ru) 2005-08-25
HUP9701777A2 (hu) 1999-06-28
GB9911557D0 (en) 1999-07-21
SI1369115T1 (sl) 2006-12-31
DE69721692D1 (de) 2003-06-12
EP0839533A1 (en) 1998-05-06
DK0839532T3 (da) 2003-08-25
DK1369115T3 (da) 2007-01-02
ATE239475T1 (de) 2003-05-15
WO1998018449A1 (en) 1998-05-07
BG63841B1 (bg) 2003-03-31
MY121623A (en) 2006-02-28
BE1011382A5 (fr) 1999-08-03
HUP9701778A2 (hu) 1999-01-28
MX9708341A (es) 1998-08-30
AU731388B2 (en) 2001-03-29
PT1369115E (pt) 2006-12-29
RO120813B1 (ro) 2006-08-30
GB9722796D0 (en) 1997-12-24
HK1010495A1 (en) 1999-06-25
IS5035A (is) 1999-04-27
IE970772A1 (en) 2000-02-09
EP0839532A1 (en) 1998-05-06
SI0839532T1 (en) 2003-10-31
AR010538A1 (es) 2000-06-28
SK55999A3 (en) 2000-06-12
EP1369115B1 (en) 2006-09-06
JPH10147529A (ja) 1998-06-02
EE9900162A (et) 1999-12-15
NO322468B1 (no) 2006-10-09
BG103369A (en) 2000-05-31
CH693820A5 (fr) 2004-02-27
BE1011381A5 (fr) 1999-08-03
FR2756490B1 (fr) 2003-06-20
BR9712703A (pt) 1999-10-26
AU4364897A (en) 1998-05-07
IL122025A (en) 2003-01-12
SG72765A1 (en) 2000-05-23
YU42397A (sh) 2000-10-30
AP971A (en) 2001-05-30
GB9722801D0 (en) 1997-12-24
DE69736644D1 (de) 2006-10-19
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
PL315941A1 (en) 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
HK1020949A1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
HK1032958A1 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments.
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
PL299284A1 (en) Benzimidazole derivatives, method of obtaining them as well as pharmaceutical preparation and method of obtaining same
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
NO307930B1 (no) Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0103387A3 (en) Quinazoline derivatives preparation thereof, medicament containing them and their intermediates
HUP9902311A3 (en) New triazolopurines, method of preparing them and their use as drugs
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
EE9800075A (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20131029